PT-65 functions as a robust GSK3 Degrader utilizing the PROTAC mechanism. Demonstrating significant activity against GSK3α and GSK3β, it effectively mitigates Okadaic acid-induced tau hyperphosphorylation. Additionally, PT-65 showcases the ability to improve learning and memory deficits in rat models of Alzheimer's disease.
Usually ships within 24 hours.